216 related articles for article (PubMed ID: 25701612)
1. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
Zhang W; Wang G; See E; Shaw JP; Baguley BC; Liu J; Amirapu S; Wu Z
J Control Release; 2015 Apr; 203():161-9. PubMed ID: 25701612
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
[TBL] [Abstract][Full Text] [Related]
3. Improving drug retention in liposomes by aging with the aid of glucose.
Zhang W; Falconer JR; Baguley BC; Shaw JP; Kanamala M; Xu H; Wang G; Liu J; Wu Z
Int J Pharm; 2016 May; 505(1-2):194-203. PubMed ID: 27021465
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
[TBL] [Abstract][Full Text] [Related]
5. Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.
Zhang W; Li C; Jin Y; Liu X; Wang Z; Shaw JP; Baguley BC; Wu Z; Liu J
Drug Deliv; 2018 Nov; 25(1):611-622. PubMed ID: 29493300
[TBL] [Abstract][Full Text] [Related]
6. Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug.
Zhang W; Wang G; Falconer JR; Baguley BC; Shaw JP; Liu J; Xu H; See E; Sun J; Aa J; Wu Z
Pharm Res; 2015 Apr; 32(4):1451-61. PubMed ID: 25355460
[TBL] [Abstract][Full Text] [Related]
7. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs.
El Kechai N; Bochot A; Huang N; Nguyen Y; Ferrary E; Agnely F
Int J Pharm; 2015 Jun; 487(1-2):187-96. PubMed ID: 25882015
[TBL] [Abstract][Full Text] [Related]
8. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
10. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells.
Yang MM; Wilson WR; Wu Z
Int J Pharm; 2017 Jan; 516(1-2):323-333. PubMed ID: 27871834
[TBL] [Abstract][Full Text] [Related]
12. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.
Ganta S; Paxton JW; Baguley BC; Garg S
Int J Pharm; 2009 Feb; 367(1-2):179-86. PubMed ID: 18848873
[TBL] [Abstract][Full Text] [Related]
13. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
[TBL] [Abstract][Full Text] [Related]
14. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
16. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
17. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
Zhang J; Chen Y; Li X; Liang X; Luo X
Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
[TBL] [Abstract][Full Text] [Related]
18. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
20. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina.
Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY
Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
